We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Global Lab Automation Market to Reach USD 5.20 Billion by 2022

By LabMedica International staff writers
Posted on 28 Nov 2017
The global lab automation market is expected to grow at a CAGR of 5.1% from USD 4.06 billion in 2017 to USD 5.20 billion by 2022, driven by process miniaturization, high demand in drug discovery and clinical diagnostics, higher reproducibility and accuracy, and a large workforce demand and supply gap. More...
Additionally, enhanced productivity and reduced costs, better personnel safety, and small volumes of samples and reagents offered by lab automation are expected to further aid the market growth. However, the high cost of lab automation is limiting its adoption among small and medium-sized labs, which is expected to restrict the market growth.

These are the latest findings of MarketsandMarkets (Northbrook, IL, USA), a global market research company.

On the basis of equipment and software, the software segment is expected to witness the highest growth in the lab automation market during the forecast period, led by the increasing need for efficient data storage, analysis, and sharing methods. Based on application, the genomics solutions segment is expected to register the highest CAGR in the lab automation market during the forecast period, driven by the growing need for high-throughput genomics in research labs, increase in genetic testing in diagnostic labs, and better accuracy and reproducibility.

On the basis of region, North America is expected to command the largest share of the global lab automation market in 2017, while Asia-Pacific is expected to register the highest CAGR during the forecast period. The growth of the Asia-Pacific lab automation market will be driven by the region’s growing economy, increasing healthcare investments leading to increased research activities and adoption of automated systems in clinical diagnostics and drug discovery, large population pool, improving public health awareness, and rising demand for standardization and accreditation in laboratory practices. The ongoing trends in the global lab automation market include process automation, miniaturization, incorporation of robotics in lab automation workflows and expansion of product distribution networks in the Asia-Pacific region.

Related Links:
MarketsandMarkets


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.